Gritstone Asset Management’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Gritstone Asset Management’s Portfolio ORIAW Stock Details ORIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-267,722	Closed	-$21.4K	–	174
2023 Q1	$21.4K	Sell	267,722 -8,278	-3%	-$2.16K	0.03%	136
2022 Q4	$41.9K	Buy	+276,000	New	+$31.7K	0.05%	135

Gritstone Asset Management's ORIAW Position: Q2 2023 in Review

Gritstone Asset Management sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q2 2023, closing a stake of 267,722 shares — an estimated $21.4K sold.

Gritstone Asset Management first reported a position in ORIAW in Q4 2022 and held it in 2 quarters. The position peaked at $41.9K in Q4 2022. 0 funds tracked by Wall St. Rank hold ORIAW as of Q2 2023.

Gritstone Asset Management reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Gritstone Asset Management sold 267,722 Orion Biotech Opportunities Corp. Warrant shares in Q2 2023, an estimated $21.4K.
Gritstone Asset Management first reported a position in Orion Biotech Opportunities Corp. Warrant in Q4 2022 and held it in 2 quarters.
Gritstone Asset Management's Orion Biotech Opportunities Corp. Warrant position peaked at $41.9K in Q4 2022.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q2 2023.

Based on Gritstone Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.